ter Borg E J, Horst G, Limburg P C, van Venrooij W J, Kallenberg C G
Department of Internal Medicine, University Hospital, Groningen, The Netherlands.
J Rheumatol. 1991 Mar;18(3):363-7.
In order to investigate whether disease exacerbations of systemic lupus erythematosus (SLE) are accompanied or preceded by changes in antibody levels against the U1RNA associated 70 kDa and A polypeptides, we prospectively collected plasma specimens from 71 patients with SLE. We compared changes in anti-70 kDa/anti-A levels, measured by ELISA using cloned antigens, with changes in levels of anti-dsDNA and total IgG. Measurable levels of anti-70 kDa (n = 10) and/or anti-A antibodies (n = 6) were detected during 10 exacerbations. Four of the 10 exacerbations with a measurable level of anti-70 kDa antibodies were preceded by a significant rise in anti-70 kDa levels, 2 by a significant fall, while levels of anti-70 kDa did not change in the remaining 4 cases. Only one of the 6 exacerbations with detectable anti-A antibody levels was preceded by a significant rise in anti-A antibodies, while levels did not change before exacerbation in the other 5 cases. Six of the 10 exacerbations were preceded by a significant rise in anti-dsDNA; in 4 cases levels of anti-dsDNA did not change before exacerbation. In contrast to anti-dsDNA, no relation was found between changes in levels of anti-70 kDa/anti-A and changes in disease activity. Significant changes in levels of anti-70 kDa/anti-A, occurring in 6 cases, were accompanied by parallel changes in total IgG in 5 of these 6. We conclude that, in contrast to anti-dsDNA, serial measurement of levels of anti-70 kDa/anti-A is not useful for monitoring disease activity or predicting disease exacerbations in SLE.(ABSTRACT TRUNCATED AT 250 WORDS)
为了研究系统性红斑狼疮(SLE)病情加重是否伴随或先于抗U1RNA相关70 kDa和A多肽抗体水平的变化,我们前瞻性地收集了71例SLE患者的血浆样本。我们将使用克隆抗原通过酶联免疫吸附测定(ELISA)测得的抗70 kDa/抗A水平变化与抗双链DNA(dsDNA)和总IgG水平变化进行了比较。在10次病情加重期间检测到了可测量水平的抗70 kDa(n = 10)和/或抗A抗体(n = 6)。在10次有可测量抗70 kDa抗体水平的病情加重中,4次之前抗70 kDa水平显著升高,2次之前显著下降,其余4例抗70 kDa水平未发生变化。在6次有可检测抗A抗体水平的病情加重中,只有1次之前抗A抗体显著升高,其他5例在病情加重前水平未发生变化。10次病情加重中有6次之前抗dsDNA显著升高;4例在病情加重前抗dsDNA水平未发生变化。与抗dsDNA不同,未发现抗70 kDa/抗A水平变化与疾病活动度变化之间存在关联。6例抗70 kDa/抗A水平发生显著变化,其中5例总IgG水平也随之平行变化。我们得出结论,与抗dsDNA不同,连续测量抗70 kDa/抗A水平对监测SLE疾病活动度或预测病情加重并无帮助。(摘要截选至250字)